• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Netherlands ENT Devices Investment Opportunities, Analysis and Forecasts to 2012 Product Image

Netherlands ENT Devices Investment Opportunities, Analysis and Forecasts to 2012

  • Published: December 2008
  • 86 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Cochlear Limited
  • Entermed BV
  • GN ReSound A/S
  • MED-EL
  • Phonak Holding AG
  • MORE

Netherlands ENT Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Netherlands ENT devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ENT devices in Netherlands

Scope

- The report provides ENT devices information broken down into detailed categories and segments in Netherlands.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- READ MORE >

1 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of the Markets Covered in the Report 12
3.1 ENT Devices 12
3.2 Hearing Aid Devices 12
3.2.1 Analog Hearing Devices 12
3.2.2 Digital Signal Processing Hearing Aid (DSP) 12
3.3 Hearing Implants 12
3.3.1 Cochlear Implant 12
3.3.2 Bone Anchored Hearing Implant 12
3.4 Diagnostic Devices 13
3.4.1 Audiometer 13
3.4.2 Otoscope 13
4 Healthcare Sector Review 14
4.1 Healthcare Expenditure 14
4.2 Healthcare Infrastructure 17
4.3 Healthcare Policy 19
4.3.1 Health Insurance Act 20
4.3.2 Healthcare Allowance Act 20
4.3.3 The Exceptional Medical Expenses Act 20
5 Regulation System 21
5.1 Medical Equipment Approval Process 21
5.1.1 Classification of Medical Devices 22
5.1.2 Conformity Assessment Process 31
5.2 Post Market Surveillance (PMS) 34
6 Pricing and Reimbursement 35
6.1 Pricing and Reimbursement in Netherlands 35
7 Distribution Structure 36
7.1 Distribution Structure in Netherlands 36
8 ENT Devices In Netherlands 37
8.1 ENT Devices Cross Country Comparison (2000-2012) 37
8.2 ENT Devices, Netherlands, Overall Revenues ($ mn), 2000-2012 38
8.3 ENT Devices, Netherlands, Category Volume (Units), 2000-2012 42
8.4 ENT Devices, Netherlands, Company Share (2006-2007) 44
9 Diagnostic Devices In Netherlands 45
9.1 Diagnostic Devices Overall Revenue (2000-2012) 45
9.2 Diagnostic Devices Overall Volume (2000-2012) 47
9.3 Diagnostic Devices Average Price (2000-2012) 49
9.4 Diagnostic Devices Distribution Share (2006-2007) 50
9.5 Diagnostic Devices, Netherlands, Company Share (2006-2007) 51
10 Hearing Aid Devices In Netherlands 52
10.1 Hearing Aid Devices Overall Revenue (2000-2012) 52
10.2 Hearing Aid Devices Overall Volume (2000-2012) 54
10.3 Hearing Aid Devices Average Price (2000-2012) 56
10.4 Hearing Aid Devices Distribution Share (2006-2007) 57
10.5 Hearing Aid Devices, Netherlands, Company Share (2006-2007) 58
11 Hearing Implants In Netherlands 59
11.1 Hearing Implants Overall Revenue (2000-2012) 59
11.2 Hearing Implants Overall Volume (2000-2012) 61
11.3 Hearing Implants Average Price (2000-2012) 63
11.4 Hearing Implants Distribution Share (2006-2007) 64
11.5 Hearing Implants, Netherlands, Company Share (2006-2007) 65
12 William Demant Holding A/S Company Profile 66
12.1 Company Overview 66
12.2 Value Chain Analysis 66
12.2.1 Manufacturing 67
12.2.2 Product Development 67
12.2.3 Sales and Marketing 67
13 GN ReSound A/S Company Profile 68
13.1 Company Overview 68
14 Phonak Holding AG Company Profile 69
14.1 Company Overview 69
14.2 Value Chain Analysis 69
14.2.1 Manufacturing 70
14.2.2 Product Development 70
14.2.3 Sales and Marketing 70
15 Cochlear Limited Company Profile 72
15.1 Company Overview 72
15.2 Value Chain Analysis 72
15.2.1 Manufacturing 73
15.2.2 Product Development 73
15.2.3 Sales and Marketing 74
16 MED-EL Company Profile 75
16.1 Company Overview 75
16.1.1 MED-EL Pipeline Products by Equipment Type 76
16.1.2 MED-EL Pipeline Products by Development Stage 76
16.1.3 MED-EL Pipeline Products by Therapy Area 76
16.1.4 MED-EL Pipeline Products by Clinical Trials 76
16.1.5 MED-EL Pipeline Products by News Summary 76
17 Advanced Bionics Corporation Company Profile 77
17.1 Company Overview 77
17.1.1 Advanced Bionics Corporation Pipeline Products by Equipment Type 78
17.1.2 Advanced Bionics Corporation Pipeline Products by Development Stage 78
17.1.3 Advanced Bionics Corporation Pipeline Products by Therapy Area 78
17.1.4 Advanced Bionics Corporation Pipeline Products by Clinical Trials 78
17.1.5 Advanced Bionics Corporation Pipeline Products By News Summary 78
18 Entermed BV Company Profile 79
18.1 Company Overview 79
19 Medi Technisch Laboratorium "Formaat" Holding B.V. Company Profile 80
19.1 Company Overview 80
20 Appendix 81
20.1 Global Markets Direct Research Methodology 81
20.2 Coverage 82
20.3 Secondary Research 82
20.4 Primary Research 83
20.5 Models 83
20.6 Forecasts 84
20.7 Expert Panels 84
20.8 Currency Conversion 85
20.9 Contact Us 86
20.10 Disclaimer 86

Executive Summary

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006 15
Figure 2: Healthcare Financing Framework in Netherlands, 2005 16
Figure 3: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007 23
Figure 4: Flowchart for Classification of Invasive Devices in Netherlands, 2007 24
Figure 5: Flowchart for Classification of Invasive Devices in Netherlands, 2007 25
Figure 6: Flowchart for Classification of Invasive Devices in Netherlands, 2007 26
Figure 7: Flowchart for Classification of Invasive Devices in Netherlands, 2007 27
Figure 8: Flowchart for Classification of Active Devices in Netherlands, 2007 28
Figure 9: Flowchart for Classification of Active Devices in Netherlands, 2007 29
Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007 30
Figure 11: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007 31
Figure 12: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007 32
Figure 13: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007 33
Figure 14: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007 34
Figure 15: ENT Devices Cross Country Comparison (2000-2012) 37
Figure 16: ENT Devices, Netherlands, Overall Revenues ($ mn), 2000-2012 38
Figure 17: ENT Devices, Netherlands, Portfolio Analysis, 2000-2012 39
Figure 18: ENT Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 40
Figure 19: ENT Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012 41
Figure 20: ENT Devices, Netherlands, Category Volume (Units), 2000-2012 42
Figure 21: ENT Devices, Netherlands, Company Share (%), 2007 44
Figure 22: Diagnostic Devices, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2007 45
Figure 23: Diagnostic Devices, Netherlands, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 24: Diagnostic Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007 47
Figure 25: Diagnostic Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012 48
Figure 26: Diagnostic Devices, Netherlands, Company Share (%), 2007 51
Figure 27: Hearing Aid Devices, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2007 52
Figure 28: Hearing Aid Devices, Netherlands, Revenue ($ mn) by Segment, Forecast, 2007-2012 53
Figure 29: Hearing Aid Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007 54
Figure 30: Hearing Aid Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012 55
Figure 31: Hearing Aid Devices, Netherlands, Company Share (%), 2007 58
Figure 32: Hearing Implants, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2007 59
Figure 33: Hearing Implants, Netherlands, Revenue ($ mn) by Segment, Forecast, 2007-2012 60
Figure 34: Hearing Implants, Netherlands, Overall Volume (Units), Historic, 2000-2007 61
Figure 35: Hearing Implants, Netherlands, Overall Volume (Units), Forecast, 2007-2012 62
Figure 36: Hearing Implants, Netherlands, Company Share (%), 2007 65
Figure 37: William Demant Holding A/S Value Chain Analysis 66
Figure 38: Phonak Holding AG Value Chain Analysis 69
Figure 39: Cochlear Limited Value Chain Analysis 72
Figure 40: Global Markets Direct Methodology 81

William Demant Holding A/S
GN ReSound A/S
Phonak Holding AG
Cochlear Limited
MED-EL
Advanced Bionics Corporation
Entermed BV
Medi Technisch Laboratorium "Formaat" Holding B.V.

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos